Leading Contract Research Organisation, Syntagon, Launches New Web Site

Specialist contract research organisation, Syntagon, is launching a new Web site designed to provide easily accessible information about the group’s process development and analytical capabilities.

The new site, http://ww.syntagon.com, offers visitors in-depth information on Syntagon’s services, current industry news, state-of-the art laboratories and a wider variety of case studies.

“The new Syntagon site is designed to be welcoming and easy to use for a broader audience than has been the case in the past. We are striving to show people the benefits of working with Syntagon, rather than just telling people what we do,” says Syntagon Sales and Marketing Director, John Cameron.

“We wanted the Web site to be more closely aligned to our strategic strengths – providing the right ingredients for a successful start to clinical trials – as well as being informative to our customers,” adds Cameron.

Syntagon’s process development expertise, analytical chemistry and crystallisation services are tailored for all client types: from single-product start-ups, to global pharmaceutical groups.

Established in 1998, Syntagon is an independent company owned by founders Paul Alhadeff and Michael Lofthagen. Syntagon’s management team has extensive large-pharma and biotechnology experience.

With twin operations in Södertälje, Sweden, and Riga, Latvia, Syntagon specialises in synthetic preparation and analysis of small molecules under GMP manufacture.